MedTrace Logo

Interest of Procore Needle® for Diagnosis of Lung Cancer

NCT02931461 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2020-06-02

No results posted yet for this study

Summary

The ProCore ultrasound biopsy needle, used primarily to obtain intra-abdominal tissue core biopsies, has not been widely used for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In this study the investigators are going to evaluate the utility of the ProCore needle for sampling mediastinal or hilar lymph nodes during EBUS-TBNA versus standard 22 gauge needle for diagnosis of lung cancer.

Conditions

  • Endobronchial Transbronchial Needle Aspiration Lung Cancer Procore

Interventions

PROCEDURE

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Sponsors & Collaborators

  • Poitiers University Hospital

    lead OTHER

Study Design

Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-27
Primary Completion
2018-07-16
Completion
2018-07-16

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02931461 on ClinicalTrials.gov